Selected research
Market Structure
Global C-C Chemokine Receptor Type 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global C-C Chemokine Receptor Type 5 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of C-C Chemokine Receptor Type 5 include Allergan Plc, American Gene Technologies International Inc, Bristol-Myers Squibb Company, ChemoCentryx Inc, Cytodyn Inc, Pharis Biotec GmbH, GlaxoSmithKline Plc and TaiwanJ Pharmaceuticals Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global C-C Chemokine Receptor Type 5 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of C-C Chemokine Receptor Type 5 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents C-C Chemokine Receptor Type 5 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C-C Chemokine Receptor Type 5 market size, projected growth trends, production technologies, key applications, and end-use industries.
C-C Chemokine Receptor Type 5 Segment by Company
Allergan Plc
American Gene Technologies International Inc
Bristol-Myers Squibb Company
ChemoCentryx Inc
Cytodyn Inc
Pharis Biotec GmbH
GlaxoSmithKline Plc
TaiwanJ Pharmaceuticals Co Ltd
C-C Chemokine Receptor Type 5 Segment by Type
DS-001
CCL-14
BMS-813160
AG-1105
Others
C-C Chemokine Receptor Type 5 Segment by Application
Infectious Disease
Immunology
Gastrointestinal
Oncology
Others
C-C Chemokine Receptor Type 5 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 5.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the C-C Chemokine Receptor Type 5 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 5 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of C-C Chemokine Receptor Type 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of C-C Chemokine Receptor Type 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DS-001
- CCL-14
- BMS-813160
- AG-1105
- Others
Applications
- Infectious Disease
- Immunology
- Gastrointestinal
- Oncology
- Others
Companies covered
- Allergan Plc
- American Gene Technologies International Inc
- Bristol-Myers Squibb Company
- ChemoCentryx Inc
- Cytodyn Inc
- Pharis Biotec GmbH
- GlaxoSmithKline Plc
- TaiwanJ Pharmaceuticals Co Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global C-C Chemokine Receptor Type 5 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global C-C Chemokine Receptor Type 5 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global C-C Chemokine Receptor Type 5 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global C-C Chemokine Receptor Type 5 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global C-C Chemokine Receptor Type 5 Market Dynamics
- 2.1 C-C Chemokine Receptor Type 5 Industry Trends
- 2.2 C-C Chemokine Receptor Type 5 Industry Drivers
- 2.3 C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges
- 2.4 C-C Chemokine Receptor Type 5 Industry Restraints
3 C-C Chemokine Receptor Type 5 Market by Manufacturers
- 3.1 Global C-C Chemokine Receptor Type 5 Revenue by Manufacturers (2021-2026)
- 3.2 Global C-C Chemokine Receptor Type 5 Sales by Manufacturers (2021-2026)
- 3.3 Global C-C Chemokine Receptor Type 5 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global C-C Chemokine Receptor Type 5 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global C-C Chemokine Receptor Type 5 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global C-C Chemokine Receptor Type 5 Manufacturers, Product Type & Application
- 3.7 Global C-C Chemokine Receptor Type 5 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global C-C Chemokine Receptor Type 5 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025
- 3.8.3 2025 C-C Chemokine Receptor Type 5 Tier 1, Tier 2, and Tier 3
4 C-C Chemokine Receptor Type 5 Market by Type
- 4.1 C-C Chemokine Receptor Type 5 Type Introduction
- 4.1.1 DS-001
- 4.1.2 CCL-14
- 4.1.3 BMS-813160
- 4.1.4 AG-1105
- 4.1.5 Others
- 4.2 Global C-C Chemokine Receptor Type 5 Sales by Type
- 4.2.1 Global C-C Chemokine Receptor Type 5 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2032)
- 4.2.3 Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2032)
- 4.3 Global C-C Chemokine Receptor Type 5 Revenue by Type
- 4.3.1 Global C-C Chemokine Receptor Type 5 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global C-C Chemokine Receptor Type 5 Revenue by Type (2021-2032)
- 4.3.3 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2032)
5 C-C Chemokine Receptor Type 5 Market by Application
- 5.1 C-C Chemokine Receptor Type 5 Application Introduction
- 5.1.1 Infectious Disease
- 5.1.2 Immunology
- 5.1.3 Gastrointestinal
- 5.1.4 Oncology
- 5.1.5 Others
- 5.2 Global C-C Chemokine Receptor Type 5 Sales by Application
- 5.2.1 Global C-C Chemokine Receptor Type 5 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2032)
- 5.2.3 Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2032)
- 5.3 Global C-C Chemokine Receptor Type 5 Revenue by Application
- 5.3.1 Global C-C Chemokine Receptor Type 5 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global C-C Chemokine Receptor Type 5 Revenue by Application (2021-2032)
- 5.3.3 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2032)
6 Global C-C Chemokine Receptor Type 5 Sales by Region
- 6.1 Global C-C Chemokine Receptor Type 5 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2032)
- 6.2.1 Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026)
- 6.2.2 Global C-C Chemokine Receptor Type 5 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global C-C Chemokine Receptor Type 5 Revenue by Region
- 7.1 Global C-C Chemokine Receptor Type 5 Revenue by Region
- 7.1.1 Global C-C Chemokine Receptor Type 5 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global C-C Chemokine Receptor Type 5 Revenue by Region (2021-2026)
- 7.1.3 Global C-C Chemokine Receptor Type 5 Revenue by Region (2027-2032)
- 7.1.4 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America C-C Chemokine Receptor Type 5 Revenue (2021-2032)
- 7.2.2 North America C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe C-C Chemokine Receptor Type 5 Revenue (2021-2032)
- 7.3.2 Europe C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific C-C Chemokine Receptor Type 5 Revenue (2021-2032)
- 7.4.2 Asia-Pacific C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Allergan Plc
- 8.1.1 Allergan Plc Company Information
- 8.1.2 Allergan Plc Business Overview
- 8.1.3 Allergan Plc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio
- 8.1.5 Allergan Plc Recent Developments
- 8.2 American Gene Technologies International Inc
- 8.2.1 American Gene Technologies International Inc Company Information
- 8.2.2 American Gene Technologies International Inc Business Overview
- 8.2.3 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio
- 8.2.5 American Gene Technologies International Inc Recent Developments
- 8.3 Bristol-Myers Squibb Company
- 8.3.1 Bristol-Myers Squibb Company Company Information
- 8.3.2 Bristol-Myers Squibb Company Business Overview
- 8.3.3 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio
- 8.3.5 Bristol-Myers Squibb Company Recent Developments
- 8.4 ChemoCentryx Inc
- 8.4.1 ChemoCentryx Inc Company Information
- 8.4.2 ChemoCentryx Inc Business Overview
- 8.4.3 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio
- 8.4.5 ChemoCentryx Inc Recent Developments
- 8.5 Cytodyn Inc
- 8.5.1 Cytodyn Inc Company Information
- 8.5.2 Cytodyn Inc Business Overview
- 8.5.3 Cytodyn Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio
- 8.5.5 Cytodyn Inc Recent Developments
- 8.6 Pharis Biotec GmbH
- 8.6.1 Pharis Biotec GmbH Company Information
- 8.6.2 Pharis Biotec GmbH Business Overview
- 8.6.3 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio
- 8.6.5 Pharis Biotec GmbH Recent Developments
- 8.7 GlaxoSmithKline Plc
- 8.7.1 GlaxoSmithKline Plc Company Information
- 8.7.2 GlaxoSmithKline Plc Business Overview
- 8.7.3 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio
- 8.7.5 GlaxoSmithKline Plc Recent Developments
- 8.8 TaiwanJ Pharmaceuticals Co Ltd
- 8.8.1 TaiwanJ Pharmaceuticals Co Ltd Company Information
- 8.8.2 TaiwanJ Pharmaceuticals Co Ltd Business Overview
- 8.8.3 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio
- 8.8.5 TaiwanJ Pharmaceuticals Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 C-C Chemokine Receptor Type 5 Value Chain Analysis
- 9.1.1 C-C Chemokine Receptor Type 5 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 C-C Chemokine Receptor Type 5 Production Mode & Process
- 9.2 C-C Chemokine Receptor Type 5 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 C-C Chemokine Receptor Type 5 Distributors
- 9.2.3 C-C Chemokine Receptor Type 5 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst